Literature DB >> 30875640

Taming a beast: lessons from the domestication of hepatitis C virus.

Joseph M Luna1, Mohsan Saeed1, Charles M Rice2.   

Abstract

"What I cannot create, I do not understand." Richard Feynman may have championed reasoning from first principles in his famous blackboard missive, but he could just as well have been referring to the plight of a molecular virologist. What cannot be grown in a controlled laboratory setting, we cannot fully understand. The story of the laboratory domestication of hepatitis C virus (HCV) is now a classic example of virologists applying all manner of inventive skill to create cell-based models of infection in order to clarify prospective drug targets. In this review, we highlight key successes and failures that were instructive in achieving cell-based models for HCV studies and drug development. We also emphasize the lessons learned from the ∼40 year saga that may be applicable to viruses yet unknown and uncultured.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30875640      PMCID: PMC6556422          DOI: 10.1016/j.coviro.2019.02.008

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  96 in total

1.  Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.

Authors:  J H Hoofnagle; K D Mullen; D B Jones; V Rustgi; A Di Bisceglie; M Peters; J G Waggoner; Y Park; E A Jones
Journal:  N Engl J Med       Date:  1986-12-18       Impact factor: 91.245

2.  Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee.

Authors:  M Yanagi; R H Purcell; S U Emerson; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

Review 3.  25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end.

Authors:  Markus H Heim
Journal:  Nat Rev Immunol       Date:  2013-06-07       Impact factor: 53.106

Review 4.  Innate immunity and HCV.

Authors:  Markus H Heim
Journal:  J Hepatol       Date:  2012-10-11       Impact factor: 25.083

5.  A genome-wide genetic screen for host factors required for hepatitis C virus propagation.

Authors:  Qisheng Li; Abraham L Brass; Aylwin Ng; Zongyi Hu; Ramnik J Xavier; T Jake Liang; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-27       Impact factor: 11.205

6.  Peptide-based inhibitors of the hepatitis C virus serine protease.

Authors:  M Llinàs-Brunet; M Bailey; G Fazal; S Goulet; T Halmos; S Laplante; R Maurice; M Poirier; M A Poupart; D Thibeault; D Wernic; D Lamarre
Journal:  Bioorg Med Chem Lett       Date:  1998-07-07       Impact factor: 2.823

7.  Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs.

Authors:  P J Bredenbeek; I Frolov; C M Rice; S Schlesinger
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

Review 8.  Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development.

Authors:  Volker Lohmann
Journal:  Med Microbiol Immunol       Date:  2018-10-08       Impact factor: 3.402

9.  Intercistronic as well as terminal sequences are required for efficient amplification of brome mosaic virus RNA3.

Authors:  R French; P Ahlquist
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

10.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

View more
  3 in total

1.  Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 Mpro/3CLpro in Living Cells.

Authors:  Seyed Arad Moghadasi; Morgan A Esler; Yuka Otsuka; Jordan T Becker; Sofia N Moraes; Constance B Anderson; Srinivas Chamakuri; Christopher Belica; Chloe Wick; Daniel A Harki; Damian W Young; Louis Scampavia; Timothy P Spicer; Ke Shi; Hideki Aihara; William L Brown; Reuben S Harris
Journal:  mBio       Date:  2022-04-26       Impact factor: 7.786

2.  Editorial overview: Antiviral strategies: Antiviral drug development for single-stranded RNA viruses.

Authors:  Margo A Brinton; Richard K Plemper
Journal:  Curr Opin Virol       Date:  2019-05-29       Impact factor: 7.090

Review 3.  Viral hepatitis update: Progress and perspectives.

Authors:  María B Pisano; Cecilia G Giadans; Diego M Flichman; Viviana E Ré; María V Preciado; Pamela Valva
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.